HOXB2 as a novel prognostic indicator for stage I lung adenocarcinomas.
Inamura K, Togashi Y, Okui M, Ninomiya H, Hiramatsu M, Satoh Y, Okumura S, Nakagawa K, Shimoji T, Noda T, Ishikawa Y.
Inamura K, et al.
J Thorac Oncol. 2007 Sep;2(9):802-7. doi: 10.1097/JTO.0b013e3181461987.
J Thorac Oncol. 2007.
PMID: 17805056
Free article.